MultiCell Technologies

MCET

Biotechnology · Healthcare

Price

$0.00

+0.00 (+0.00%)

Market Cap

$50,009

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Share count rising — dilution

+94.5% over 1y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 1.9M (2013) → 3.7M (2014)

MultiCell Technologies is a small biotechnology company focused on developing experimental drugs and therapies. It works on treatments targeting conditions related to the nervous system and metabolic diseases. The company does not yet sell products to consumers — it is in the research and development stage, meaning its drugs are still being tested and have not received regulatory approval.

MultiCell generates little to no product revenue and funds its operations primarily through financing activities such as stock issuances. Its operating margin is deeply negative, which is typical for early-stage biotech firms that spend heavily on research while earning almost nothing in return. The biggest risk the company faces is running out of cash before any of its experimental treatments can complete clinical trials and reach the market, a challenge that affects many small biotechs of its size.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

>+1,000% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-170.5% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$324/ year

→ Flat (+3% vs prior year)

656.0% of revenue

36.4x the sector average (18%)

Steady R&D investment year-over-year

Insider Activity

10.0%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~11 months

$281 cash & investments

Short runway — potential dilution ahead through share issuance

Revenue accelerating

MultiCell Technologies grew revenue 1480% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

23.7%

Thin — 23.7% gross margin

Operating Margin

-90.9%

Losing money on operations — -90.9%

ROCE

-0.5%

Weak — -0.5% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+1532.7%

Fast-growing sales (1532.7% YoY)

EPS YoY

-93.8%

Earnings shrinking (-93.8% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-24.6%

Burning cash (-24.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

0.0x

Attractive valuation — P/E 0.0

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial